Source:http://linkedlifedata.com/resource/pubmed/id/13679624
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 10
|
pubmed:dateCreated |
2003-9-18
|
pubmed:abstractText |
Creutzfeldt-Jakob disease can develop in subjects given a cadaveric dura mater graft (dCJD). This disease has a phenotypic heterogeneity despite the lack of genetic variation. Numerous plaque-type prion protein (PrP) deposits are found in the brain of some but not all subjects; hence, there may be two subtypes of this clinical entity. To validate dCJD subtypes further, we carried out a larger-scale clinicopathological analysis and typing of protease-resistant PrP (PrP(Sc)) in dCJD cases. Cases with plaque-type PrP deposits (p-dCJD) were shown to be distinct from those without PrP plaques (np-dCJD), from several clinicopathological aspects. Analysis of PrP(Sc) revealed that, while the major PrP(Sc) species from both subtypes was of 21 kDa after deglycosylation (type 1 PrP(Sc)), a C-terminal PrP fragment of 11-12 kDa (fPrP11-12) was associated with np-dCJD but not with p-dCJD. The disease type-specific association of fPrP11-12 was also observed in subjects with other prion diseases. An fPrP11-12-like C-terminal PrP fragment was detected in brain lysates from patients associated with fPrP11-12, but not from patients or normal subjects unassociated with fPrP11-12. Results indicated that fPrP was produced by CJD-associated processes in vivo. The present data provide several lines of evidence that support the need for subtyping of dCJD and contribute to the understanding of the processing of disease-specific PrP species. The unique relationship of fPrP11-12 with CJD phenotype supports the view that the phenotypic heterogeneity of CJD is related to the formation of different types of disease-specific PrP and fragments thereof.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-1317
|
pubmed:author |
pubmed-author:IronsideJames WJW,
pubmed-author:KitamotoNoritoshiN,
pubmed-author:KitamotoTetsuyukiT,
pubmed-author:MohriShirouS,
pubmed-author:MuramotoTamakiT,
pubmed-author:NagashimaKazuoK,
pubmed-author:SatoTakeshiT,
pubmed-author:SatohKatsuyaK,
pubmed-author:TanakaTomoyukiT,
pubmed-author:YamadaMasahitoM
|
pubmed:issnType |
Print
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2885-93
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:13679624-Adult,
pubmed-meshheading:13679624-Aged,
pubmed-meshheading:13679624-Brain,
pubmed-meshheading:13679624-Cadaver,
pubmed-meshheading:13679624-Creutzfeldt-Jakob Syndrome,
pubmed-meshheading:13679624-Dura Mater,
pubmed-meshheading:13679624-Female,
pubmed-meshheading:13679624-Humans,
pubmed-meshheading:13679624-Male,
pubmed-meshheading:13679624-Middle Aged,
pubmed-meshheading:13679624-PrPSc Proteins,
pubmed-meshheading:13679624-Prion Diseases
|
pubmed:year |
2003
|
pubmed:articleTitle |
Association of an 11-12 kDa protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt-Jakob disease and other prion diseases.
|
pubmed:affiliation |
Department of Neurological Science, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Sendai 980-8575, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|